ANDRA AP-FONDEN – Neurocrine Biosciences, Inc. Transaction History
ANDRA AP-FONDEN portfolio value:
$6.23M
portfolio value
ANDRA AP-FONDEN quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +25.16% | 11.8K shares | 1.66M | $106.21 | 58.7K |
| Q2 2022 | share | Decrease | -31.73% | -21.8K shares | -1.27M | $97.48 | 46.9K |
| Q4 2021 | share | Increase | +33.40% | 17.2K shares | 912K | $84.63 | 68.7K |
| Q3 2021 | share | Decrease | -7.71% | -4.3K shares | -491K | $95.91 | 51.5K |
| Q2 2021 | share | Increase | +402.70% | 44.7K shares | 4.35M | $97.32 | 55.8K |
| Q1 2021 | share | Decrease | -31.06% | -5K shares | -464K | $97.25 | 11.1K |
| Q4 2020 | share | Increase | +111.84% | 8.5K shares | 812K | $95.85 | 16.1K |
| Q3 2020 | share | Decrease | -75.48% | -23.4K shares | -3.05M | $96.16 | 7.6K |
| Q2 2020 | share | Increase | +16.10% | 4.3K shares | 1.47M | $122 | 31K |
| Q1 2020 | share | Increase | +16.09% | 3.7K shares | -161K | $86.55 | 26.7K |
| Q4 2019 | share | Increase | 0.00% | 23K shares | 2.47M | $107.49 | 23K |